LUND, SWEDEN -- (MARKET WIRE) -- February 15, 2007 -- The Board of Directors of Active Biotech has decided to exercise its entitlement to request premature repayment of a convertible loan raised in 2004 through the issuance of the 2004/2009 convertible debentures.
